BeStock  
Stocks › Biotechnology › TSHA

Taysha Gene Therapies TSHA

US equityMarket cap rank #3032Biotechnology
$3.72 −$0.05 (-1.33%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $3.71 -0.27%
Open$3.67
Prev close$3.77
Day range$3.60 – $3.80
Volume3.15M
Market cap$1.21B
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

TSHA at a glance

Taysha Gene Therapies (TSHA) is trading at $3.72, down 1.33% on the day. Its market value of $1.21B makes it the 3032nd largest of the 3753 companies we follow.

It is close to the bottom of its 52-week range ($3.46 to $7.30), 49.0% under the high. Holders are behind 11.2% over twelve months, and down 37.7% across the last three months.

On the chart it has slipped under both the 50-day ($4.35) and 200-day ($5.28) moving averages; RSI is 35, and the last 30 sessions moved at roughly 74% annualized volatility.

Revenue for the quarter ended Jun 2026 was $0.00, down 100.0% from a year earlier, and a net loss of $46.64M.

4 analysts follow the stock and the average call is "buy". The mean target, $14.33, sits 285.2% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$3.70 / $3.72
Average price today$3.72
Volume3.15MAvg (90d) 3.31M
Turnover$11.72M
Turnover rate1.39%of shares outstanding
Volume ratio1.16vs. recent average pace
Day amplitude5.17%
Market cap$1.21B
Float market cap$845.64M
Shares outstanding227.32M
EPS (TTM)-$0.34
P/B3.40
Book value / share$1.10
Net profit (TTM)-$110.86M
Net assets$357.02M
30-day volatility74.4%annualized
Avg daily range (ATR)7.66%of price, 14 days
Max drawdown (1y)-49.7%-46.7% from 1y peak

Quote as of Nov 20, 2026 8:10 pm ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

C
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

B
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

F
Momentum

Trading closer to its 52-week high than most peers scores higher.

B
Wall Street

4 analysts, consensus Buy.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 16.3 · 2026-11-22 14:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation—
Growth—
Profitability2.3
Momentum12.2
Financial health49.3
Analyst view98.6

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$14.33+285.2% vs. current price
Consensus ratingBuy4 analysts covering
Morningstar fair value$7.82Price is below fair value

Wall Street’s average 12-month target is $14.33, 285.2% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $7.82, so shares trade 52.4% below that estimate. On earnings multiple, it sits in the 22nd percentile of its own five-year valuation range (cheaper than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
-1.3%
1 week
-9.3%
1 month
-7.1%
3 months
-37.7%
6 months
-32.2%
Year to date
-32.4%
1 year
-11.2%
Day range
$3.60$3.80
52-week range
$3.46$7.30

Technical signals

Full technicals →
Trend readStrong downtrend

0 bullish · 6 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average-9.8%Bearish
Price vs 50-day average-14.5%Bearish
Price vs 200-day average-29.6%Bearish
50-day vs 200-day50d below 200dBearish
RSI (14)34.7Bearish
MACD (12,26,9)-0.13Bearish
Bollinger band position-7%Neutral

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How TSHA ranks on BeStock

Market value#3019 of 3734
Closeness to 52-week high#2997 of 3724
Dollar volume today#2326 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

TSHA is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on TSHA.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on TSHA

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

TSHA stock: common questions

What is TSHA's latest share price?

$3.72 is the latest print for TSHA, a move of -1.33% against yesterday's close of $3.77. Today's low and high so far: $3.60 and $3.80.

What is TSHA worth in total?

Equity value comes to $1.21B at the current price. By that measure it is number 3032 of the 3753 names in our coverage.

Is TSHA near its 52-week high or low?

The year's floor is $3.46 and the ceiling $7.30. Shares are 49.0% away from that ceiling.

Does Taysha Gene Therapies pay a dividend?

Our data shows no dividend paid by Taysha Gene Therapies over the trailing twelve months.

Is TSHA rated a buy by Wall Street?

Of 4 analysts, 100% say buy, 0% hold and 0% sell. Price targets average $14.33, with the most cautious at $12.00 and the most optimistic at $17.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on TSHA.

Sign in to join the discussion.

Scroll to Top